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Abstract
The social patterning of cytomegalovirus (CMV) and its implication in aging suggest that the virus 
may partially contribute to socioeconomic disparities in mortality. We used Cox regression and 
inverse odds ratio weighting to quantify the proportion of the association between socioeconomic 
status (SES) and all-cause mortality that was attributable to mediation by CMV seropositivity. 
Data were from the National Health and Nutrition Examination Survey (NHANES) III (1988–
1994), with mortality follow-up through December 2011. SES was assessed as household income 
(income-to-poverty ratio ≤1.30; >1.30 to ≤1.85; >1.85 to ≤3.50; >3.50) and education (<high 
school; high school; >high school). We found strong associations between low SES and increased 
mortality: hazard ratio (HR) 1.80; 95% confidence interval (CI): 1.57, 2.06 comparing the lowest 
versus highest income groups and HR 1.29; 95% CI: 1.13, 1.48 comparing <high school versus 
>high school education. 65% of individuals were CMV seropositive, accounting for 6–15% of the 
SES-mortality associations. Age modified the associations between SES, CMV, and mortality, 
with CMV more strongly associated with mortality in older individuals. Our findings suggest that 
cytomegalovirus may partially contribute to persistent socioeconomic disparities in mortality, 
particularly among older individuals.
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1. Introduction
In 2013, over 45 million Americans were living in poverty (DeNavas-Walt and Proctor, 
2014) and 24.5 million of those over the age 25 had not completed high school (Census 
Bureau, 2013). Due to a complex and interrelated set of social, behavioral, and biological 
processes—both historical and contemporary—individuals with a lower socioeconomic 
status (SES) persistently suffer a disproportionate burden of premature mortality associated 
with a range of health conditions and have a lower overall life expectancy (Deaton, 2016; 
Chetty et al., 2016; Adler and Newman, 2002; Braveman et al., 2010; Meyer et al., 2013; 
Hummer and Hernandez, 2013; National Center for Health Statistics Health, 2011; 
Geronimus et al., 2011; Krueger et al., 2015; Muennig et al., 2010; Olshansky et al., 2012). 
While SES is clearly linked to mortality, the mechanisms underlying this disparity remain 
poorly understood.
One potential, yet under investigated, pathway through which socioeconomic disadvantage 
may “get under the skin” to impact mortality is through differential pathogen exposure 
across the life course. Prior studies have shown that low SES is associated with both 
seropositivity for (Bate et al., 2010; Cannon et al., 2010; Colugnati et al., 2007; Dowd et al., 
2009a; Dowd et al., 2009b; Staras et al., 2006; Simanek et al., 2009) and immune control of 
(Dowd et al., 2008; Dowd and Aiello, 2009; Dowd et al., 2012) the herpesvirus 
cytomegalovirus (CMV), a pathogen that once acquired persists in a latent state but is 
capable of reactivation. A parallel body of evidence suggests that seropositivity to and 
reactivation of CMV may play a key role in long-term health outcomes. Indeed, the virus has 
been implicated in the etiology of numerous chronic disease outcomes including 
cardiovascular disease, cognitive and physical decline, depression and cancer (Simanek et 
al., 2009; Aiello et al., 2006; Harkins et al., 2002; Itzhaki et al., 2004; Liu et al., 2006; 
Samanta et al., 2003; Schmaltz et al., 2005; Sorlie et al., 2000; Simanek et al., 2014; Tarter 
et al., 2014). Moreover, in previous population-based studies by the authors as well as 
others, CMV seropositivity has been shown to predict all-cause mortality (Gkrania-Klotsas 
et al., 2013; Roberts et al., 2010; Simanek et al., 2011). The exact biological mechanisms by 
which CMV may impact health are still under investigation, but a growing body of evidence 
suggests that subclinical reactivation of the virus over the life course triggers clonal 
expansion of CMV-specific memory T-cells, ultimately contributing to overall age-related 
declines in immune function and increased levels of inflammation (Derhovanessian et al., 
2011; Hadrup et al., 2006; Khan et al., 2002; Pawelec, 2013; Pawelec et al., 2009). The 
impact of CMV-driven immunosenescence may already be apparent in younger people and 
potentially accelerate as the individual ages (Turner et al., 2014). This is consistent with 
recent findings that CMV infection may enhance responses to influenza vaccination in 
young people but be detrimental in the elderly (Furman et al., 2015).
The social patterning of CMV and its implication in long-term health outcomes, including 
mortality, suggest that infection with the pathogen may partially contribute to socioeconomic 
disparities in mortality. While previous studies have identified CMV seropositivity as a key 
mediator of the association between SES and specific chronic disease outcomes (Simanek et 
al., 2009), to our knowledge, no studies have quantified the role of CMV as a mediator 
between SES and all-cause mortality at the population level. Using data from a nationally 
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representative sample of US adults, we assessed whether two factors that influence 
socioeconomic status—household income and educational attainment—were associated with 
all-cause mortality, and moreover quantified the proportions of these associations that were 
attributable to mediation by CMV seropositivity. In addition, we examined whether the 
pathways linking socioeconomic status, CMV seropositivity, and mortality were modified by 
age.
2. Methods
2.1. Study population
The data for the present study were from the National Health and Nutrition Examination 
Survey (NHANES) III (1988–1994), a population-based survey based on a multistage 
stratified probability sample. NHANES III was conducted by the National Center for Health 
Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC) and was 
designed to provide nationally representative estimates of the civilian noninstitutionalized 
US population. Full details on the NHANES III study design and response rates have been 
published previously (Anon, 1994).
Of the 39,994 individuals who participated in the NHANES III, all individuals who 
completed both the household interview and the physical examination (n = 30,818) were 
eligible for inclusion in the present analysis (see Fig. 1). To focus on adult socioeconomic 
status, we limited our analysis to individuals who were at least 25 years of age (n = 14,769), 
as has been done in prior studies (Dowd and Aiello, 2009). Fully adjusted models were 
further limited to those who had been tested for CMV and those who had complete 
information on household income and study covariates (n = 12,729). Four additional 
individuals had insufficient identifying data to confirm their mortality status in the National 
Death Index, resulting in a final sample size of 12,725.
2.2. Measures
2.2.1. Socioeconomic status—The primary exposure in the present study was 
socioeconomic status assessed as household income and educational attainment. Household 
income was measured by the income-to-poverty ratio (IPR), which was calculated by 
dividing total annual household income by the annual poverty threshold as determined by 
the US Census Bureau based on household size (for example, an IPR of 1.5 indicates that 
the family income is 1.5 times the poverty threshold). As prior studies strongly suggest that 
the income-mortality gradient is non-linear (Dowd et al., 2011), we created four categories 
for household income using the US Department of Agriculture’s food assistance program’s 
income eligibility cut-points for free (IPR≤1.30) or reduced (IPR ≤1.85) school lunches as 
recommended in the NHANES III Analytic and Reporting Guidelines (National Center for 
Health Statistics, 1996): low (IPR ≤1.30), low-middle (IPR >1.30 to ≤1.85), middle (IPR 
>1.85 to ≤3.50), and high (IPR >3.50). Educational attainment was originally assessed as the 
number of years of completed education, which we categorized as: less than high school (0 
to <12 years), high school (12 years), and more than high school (13+ years) based on 
recommended cut-points in the NHANES III guidelines (National Center for Health 
Statistics, 1996).
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2.2.2. Mortality status—To ascertain participants’ mortality status, we linked the 
NHANES III interview, examination, and laboratory data to the Public-use Linked Mortality 
File, which includes vital statistics for survey participants 18 years of age and older from the 
date of survey participation through December 31, 2011 (National Center for Health 
Statistics, 2015). All NHANES III participants with sufficient identifying information to 
confirm their mortality status in the National Death Index were included in the Public-use 
Linked Mortality File. Full details on the linkage process have been described previously 
(National Center for Health Statistics, 2011).
2.2.3. CMV serostatus—CMV serostatus (positive or negative) was the mediating 
pathway of interest. CMV specific immunoglobulin G (IgG) antibody levels were measured 
at the CDC in stored sera of NHANES III participants with an Enzyme Linked 
Immunosorbent Assay (ELISA) (Quest International, Inc., Miami FL). Sera with values near 
the ELISA cutoff were confirmed with a second ELISA assay (bioMerieux, Inc., Durham, 
NC). If results of the initial and confirmatory tests disagreed, an Immunofluorescence Assay 
(IFA) (Bion International, Inc.) was used and the result from this assay was taken as the final 
test result. This algorithm achieved 98% sensitivity and 99% specificity (Staras et al., 2006).
2.2.4. Covariates—Potential confounders of the association between SES and mortality 
were assessed via a directed acyclic graph (Greenland et al., 1999) and included the 
following sociodemographic variables: age (years), gender (female or male), race/ethnicity 
(non-Hispanic Black, non-Hispanic White, Mexican American, or Other), country of birth 
(US or other), marital status (married/cohabitating, widowed/separated/divorced, or never 
married), geographic region (Northeast, Midwest, South, or West), and urbanicity (rural or 
urban). In age-stratified analyses, age was categorized as 25–39, 40–59, and 60+ years and 
was otherwise modeled flexibly with restricted quadratic splines using the macro described 
by Howe et al., (Howe et al., 2011) with knots at the 5th, 35th, 65th, and 95th percentiles 
and slight modifications to account for the survey design.
Other covariates hypothesized to be mediators of the association between SES and mortality 
included cigarette smoking, alcohol use, body mass index (BMI), and current chronic health 
conditions. Cigarette smoking was categorized as current, former, or never. Alcohol use was 
dichotomized as current or no use. BMI was categorized base on established clinical cut-
points: <18.5 (underweight), 18.5 to <25 (normal or healthy weight), 25 to <30 
(overweight), or ≥30 (obese) (Schmaltz et al., 2005). Current chronic health conditions were 
measured with a modified Charlson index that incorporated information on the following 
comorbidities: myocardial infarction, cerebrovascular/peripheral vascular disease, chronic 
pulmonary disease, connective tissue/autoimmune disease, ulcer, liver disease, diabetes, 
moderate to severe renal disease, and any tumor (Dowd and Aiello, 2009; Charlson et al., 
1987). Points were assigned for each comorbidity and summed to create a final score as 
previously described (Charlson et al., 1987), with a higher score indicating a more sever 
burden of chronic health conditions. Scores were then categorized into three levels: ≤4, >4 to 
≤5, and >5. We did not include these potentially mediating health behaviors and biomedical 
risk factors in the adjustment set of our primary analysis that assessed the association 
between the SES variables and all-cause mortality due to the risk of introducing bias by 
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conditioning on intermediate variables (e.g., over-adjustment or collider-stratification bias) 
(Schisterman et al., 2009). However, we did assess these variables in relation to CMV 
serostatus in a secondary analysis in order to evaluate our assumption of no mediator-
outcome confounding, as described below.
2.3. Statistical analysis
All analyses were conducted in SAS 9.4 (SAS Institute, Inc., Cary, North Carolina) and 
weighted to account for the NHANES III complex survey sampling and non-response 
(National Center for Health Statistics, 1996). To preserve the complex survey design, the 
DOMAIN statement was used in SAS survey procedures to obtain results for the specific 
age group eligible for inclusion in the present study (i.e., 25+ years of age) and for all 
stratified analyses. To facilitate domain analyses, pseudo data was created for the ineligible 
subgroup (i.e., <25 years of age), as many of the analysis variables were unavailable for a 
large portion of this group (e.g., the NHANES III Public-use Linked Mortality File does not 
include participants <18 years of age) and the data values for observations in one domain 
have no impact on the results for the other domains. Missing data for the domain of interest 
(see Fig. 1) were accounted for in the computation of variance estimates by specifying the 
NOM-CAR (Not Missing Completely at Random) option in SAS (Berglund, 2016). Tests of 
statistical significance were 2-sided and the threshold for statistical significance was P < 
0.05.
Baseline was defined as the NHANES examination date and follow-up continued until the 
date of death or December 31, 2011, whichever came first. Descriptive statistics were used 
to characterize the study population at baseline, overall and within strata of SES and CMV 
serostatus. ANOVA F tests were used to assess differences between strata for continuous 
variables and Rao-Scott adjusted Pearson chi-square tests (Rao and Scott, 1984) were used 
for categorical variables. The Breslow estimator (Breslow, 1972) was used to estimate the 
cumulative probability of all-cause mortality within strata of the SES variables, adjusting for 
age, gender, race/ethnicity, country of birth, education, marital status, geographic region, and 
urbanicity. The same approach was used to estimate the cumulative probability of all-cause 
mortality by CMV serostatus, additionally adjusting for the SES variables.
To quantify the overall association between SES and all-cause mortality, Cox Proportional 
Hazard models were used to generate covariate-adjusted hazard ratios, as well as 
corresponding 95% confidence intervals (CI) using the Taylor series linearization method 
(Binder, 1983) for variance estimation. Both SES variables (household income and 
educational attainment) were included in the same model. The Efron approximation method 
was used to handle ties. To assess mediation by CMV seropositivity, we implemented the 
inverse odds ratio weighting (IORW) technique described by Nguyen et al. (Nguyen et al., 
2015) to decompose the overall association between the SES variables and all-cause 
mortality into the indirect effect mediated through CMV seropositivity and a second 
component that represented the effect of SES through all other pathways (i.e., the direct 
effect). This was achieved through a stepwise process. First, logistic regression was used to 
estimate the odds ratio for the association between the SES variables and CMV 
seropositivty. The inverse of this association was then used to weight the Cox Proportional 
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Hazards models for the association between the SES variables and mortality, which provided 
an estimate of the direct effect of the SES variables on mortality not mediated through CMV 
seropositivity. The indirect effect HR mediated through CMV seropositivity was then 
obtained by taking the exponentiated difference between the model coefficients for the total 
and direct effects. If the indirect effects were found to be statistically significant, the 
proportion of the total effect that was attributable to mediation by CMV seropositivity was 
calculated by dividing the model coefficients for the indirect effects by the model 
coefficients for the total effects. Percentile confidence intervals for the indirect effects and 
proportions mediated were obtained from 1000 bootstrap samples. To determine if the 
overall, direct, and indirect effects of SES on mortality were modified by age, results were 
compared across strata of age (25–39, 40–59, and 60+ years).
One of the necessary assumptions for the mediation analysis is no confounding of the 
mediator-outcome association conditional on covariates (Nguyen et al., 2015). This 
assumption may be violated if, for example, there are additional factors that affect both 
CMV serostatus and mortality. To further assess the assumption of no mediator-outcome 
confounding, in a sensitivity analysis we used logistic regression to estimate the association 
of four health behavior and biomedical risk factors (cigarette smoking, alcohol use, BMI, 
and current chronic health conditions) with CMV seropositivity adjusting for covariates 
included in the primary analyses (age, gender, race/ethnicity, country of birth, education, 
household income, marital status, geographic region, and urbanicity). A null association 
between a risk factor and CMV seropositivity was taken as evidence that the risk factor did 
not strongly confound the CMV-mortality association.
3. Results
3.1. Sample characteristics
Participant characteristics at the time of the NHANES examination are shown in Table 1. 
Participants were a median of 43 years of age (interquartile range [IQR]: 33–59 years), 
approximately half (52.5%) were female, and the majority reported their race/ethnicity as 
non-Hispanic White (77.4%) or non-Hispanic Black (10.6%). Overall, 28.2% had a 
household income that was low (IPR ≤1.30) or low-middle (IPR >1.30 to ≤1.85) and 58.7% 
had achieved at most a high school education. Age, gender, race/ethnicity, country of birth, 
marital status, geographic region, and urbanicity were all significantly associated with 
socioeconomic status as measured by both household income and educational attainment. Of 
the sampled population, 66.9% were CMV-seropositive. CMV seropositive participants were 
significantly more likely to have a lower income and lower educational attainment than their 
seronegative counterparts. Compared to seronegative participants, seropositive participants 
were also significantly older, more likely to be female than male, and less likely to be non-
Hispanic White or born in the US.
3.2. Overall associations with all-cause mortality
Fig. 2 shows the cumulative probability of all-cause mortality stratified by household 
income (Fig. 2a), educational attainment (Fig. 2b), and CMV serostatus (Fig. 2c). We 
observed a higher cumulative probability of mortality among low SES individuals as well as 
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among CMV seropositive individuals. The covariate adjusted hazard ratios for the overall 
all-cause mortality associations are shown in Fig. 3. Adjusting for covariates, the hazard 
ratios for the overall association between household income and all-cause mortality were 
statistically significant (see Fig. 3a): compared to high income individuals, the HR’s were 
1.80 (95% CI: 1.57, 2.06) for low income individuals, 1.70 (95% CI: 1.47, 1.96) for low-
middle income individuals, and 1.19 (95% CI: 1.06, 1.33) for middle income individuals. 
Those with less than a high school education (HR 1.29; 95% CI: 1.13, 1.48) or a high school 
education (HR 1.31; 95% CI: 1.19, 1.44) had significantly higher mortality than those who 
had attained more than a high school education (see Fig. 3b). The all-cause mortality HR 
comparing CMV seropositive individuals to seronegative individuals was 1.14 (95% CI: 
1.00, 1.30), which was only marginally significant with a P value of 0.06.
3.3. Indirect effects
Fig. 3 also shows the decomposition of the overall association between the SES variables 
and all-cause mortality into the indirect effect mediated through CMV seropositivity and a 
second component representing the effect of SES through all other pathways. We found 
modest, but statistically significant indirect effects of household income on all-cause 
mortality when comparing low to high income individuals (indirect effect HR 1.04; 95% CI: 
1.02, 1.07), low-middle to high income individuals (indirect effect HR 1.04; 95% CI: 1.02, 
1.06), and middle to high income individuals (indirect effect HR 1.02; 95% CI: 1.01, 1.04) 
(Fig. 3a). The indirect effects through CMV seropositivity accounted for 6% (95% CI: 3%, 
12%) of the overall mortality association for low compared to high income individuals, 7% 
(95% CI: 3%, 13%) for low-middle versus high income individuals, and 11% (95% CI: 5%, 
43%) for middle versus high income individuals.
Similar results were found for educational attainment, with statistically significant indirect 
effect HR’s of 1.04 (95% CI: 1.02, 1.07) comparing those with less than a high school 
education to those with greater than a high school education and of 1.02 (95% CI: 1.01, 
1.03) comparing those with a high school education to those with greater than a high school 
education (see Fig. 3b). These indirect effects accounted for 15% (95% CI: 7%, 32%) and 
7% (95% CI: 3%, 16%) of the overall education-mortality associations, respectively.
3.4. Effect modification by age
Fig. 4 shows the results of the mediation analysis for individuals who were at least 60 years 
of age (Supplemental Fig. 1 and Supplemental Fig. 2 shows the age-stratified results for all 
age groups). Age modified several of the pathways linking SES, CMV seropositivity, and 
all-cause mortality. Neither the overall association between household income and mortality, 
nor the direct effect of income on mortality not mediated through CMV were statistically 
significant in the youngest age group. Moreover, while the associations between low 
household income and CMV seropositivity were observed across all age groups, the 
association between CMV seropositivity and increased mortality did not emerge until 
middle age and was only statistically significant for those at least 60 years of age. Likewise, 
the indirect effect of household income on all-cause mortality mediated through CMV was 
only statistically significant for those in the oldest age group, which accounted for 5% (95% 
CI: 1%, 12%) of the overall income-mortality association for low compared to high income 
Feinstein et al. Page 7
Mech Ageing Dev. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
individuals, 5% (95% CI: 1%, 12%) for low-middle versus high income individuals, and 9% 
(95% CI: 2%, 28%) for middle versus high income individuals.
In contrast to what we observed for household income, the overall association between 
educational attainment and all-cause mortality, as well as the direct effect not mediated 
through CMV became weaker with increasing age. Although the associations between 
educational attainment and CMV seropositivity were strong and statistically significant 
across age groups, none of the indirect effects of educational attainment on all-cause 
mortality mediated through CMV were statistically significant.
3.5. Sensitivity analysis
The associations between CMV seropositivity and selected behavioral and clinical 
characteristics, potential confounders of the CMV-mortality association, overall and 
stratified by age, are shown in Supplemental Table 1. No statistically significant associations 
between CMV seropositivity and cigarette use, alcohol use, Charlson index, or BMI were 
detected in the overall analysis. In the age-stratified analyses, there was a statistically 
significant association between CMV seropositivity and a higher Charlson index only in the 
oldest age group.
4. Discussion
In the present study, we quantified the extent to which CMV infection contributes to 
socioeconomic disparities in all-cause mortality in a nationally representative sample of US 
adults and assessed whether the pathways linking SES, CMV, and mortality were modified 
by age. Consistent with prior studies conducted in the NHANES III cohort (Suresh et al., 
2011; Rask et al., 2009; Sabanayagam and Shankar, 2012), we found strong and statistically 
significant associations between low socioeconomic status and increased mortality in the 
overall study population. Indeed, individuals in the lowest income group were 1.8 times as 
likely to die within the follow-up period compared to those in the highest income group and 
individuals with at most a high school education were approximately 1.3 times as likely to 
die within the follow-up period compared to those who had attained more than a high school 
education. CMV infection, which affected over 65% of individuals in our sample, appeared 
to account for approximately 6–15% of these associations. Taken together, our findings 
suggest that interventions targeting the pathways linking SES, CMV, and mortality may 
reduce persistent socioeconomic disparities in mortality at the population level.
To the best of our knowledge, this is the first study to quantify the extent of the association 
between SES and mortality that is attributable to infection with CMV. However, our study 
builds on prior research that has shown an association between SES and CMV (Bate et al., 
2010; Cannon et al., 2010; Colugnati et al., 2007; Dowd et al., 2009a; Dowd et al., 2009b; 
Staras et al., 2006; Simanek et al., 2009), and between CMV and mortality (Gkrania-Klotsas 
et al., 2013; Roberts et al., 2010; Simanek et al., 2011). Notably, several studies conducted in 
US population-representative samples (including the NHANES III cohort) have shown 
significant socioeconomic disparities in CMV seroprevalence persisting across age groups, 
with lower income and education groups having a higher seroprevalence (Bate et al., 2010; 
Cannon et al., 2010; Dowd et al., 2009a; Staras et al., 2006; Simanek et al., 2009). These 
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socioeconomic gradients have been seen in children as well, with those growing up in lower 
SES households having a higher burden of infection compared to those who grow up in 
higher SES households (Dowd et al., 2009b). In our study, we observed strong and 
statistically significant associations between SES and CMV seropositivity regardless of the 
measure assessed (household income or educational attainment) and in all age groups.
Although the association between CMV seropositivity and all-cause mortality in our overall 
sample was only marginally significant (P value = 0.06), the magnitude of the association 
(HR: 1.14; 95% CI: 1:00, 1.30) was similar to statistically significant associations that have 
been demonstrated in prior population-based studies (Gkrania-Klotsas et al., 2013; Roberts 
et al., 2010; Simanek et al., 2011). For example, drawing from the same NHANES III 
sample as analyzed in the present study, Simanek et al. found that CMV seropositivity was 
significantly associated with higher all-cause mortality (HR 1.19, 95% CI: 1.01, 1.41) 
(Simanek et al., 2011). The small differences in the CMV-mortality association observed in 
this earlier study compared to the present study is likely attributable to the shorter follow-up 
period, since at the time mortality follow-up was only available through 2006, as well as 
slightly different covariate adjustment. The NHANES III findings are also consistent with a 
study by Gkrania-Klotsas et al. that was conducted in a European sample of adults 40–79 
years of age, which found that the hazard of all-cause mortality among those seropositive for 
CMV was 1.16 (95% CI: 1.07,1.26) times the hazard of mortality compared to those 
seronegative for CMV (Gkrania-Klotsas et al., 2013).
Our age-stratified analyses revealed that the associations between SES, CMV seropositivity, 
and mortality may be modified by age. Indeed, while the association between CMV 
seropositivity and all-cause mortality was only slightly above the null and non-significant in 
the youngest age group (HR 1.08; 95% CI: 0.64, 1.82), a much stronger association was 
evident among those 40–59 years of age (HR 1.38; 95% CI: 0.99, 1.93) and those 60 years 
of age and older (HR 1.26; 95% CI: 1.06, 1.48), with statistical significance only observed in 
the oldest age group. This is consistent with evidence suggesting that the immune system’s 
ability to keep CMV in a quiescent state may wane over the life course. Along these lines, a 
growing body of evidence suggests that CMV is a primary contributor to altered immune 
signatures considered characteristic of aging, as clonal expansion of CMV-specific memory 
T-cells are triggered in response to subclinical CMV reactivation over time (Derhovanessian 
et al., 2011; Hadrup et al., 2006; Khan et al., 2002; Pawelec, 2013; Pawelec and 
Derhovanessian, 2011). This is illustrated by the near universal marked accumulation of 
these late-stage differentiated potentially “senescent” CD8+ T cells seen in the majority of 
CMV-seropositive but not seronegative individuals (Derhovanessian et al., 2010), which is a 
major component of the “Immune Risk Profile” associated with 2, 4 and 6-year mortality in 
the Swedish OCTO/NONA longitudinal studies (Pawelec et al., 2009).
Not surprisingly, CMV seropositivity in our sample showed a strong age gradient, ranging 
from 53% among individuals 25–39 years of age to 86% among individuals 60 years of age 
and older. This is likely attributable to an increased cumulative probability of exposure to the 
virus over the life course, as the prevalence of CMV in the US does not appear to be 
declining over calendar time (Bate et al., 2010) and thus a strong birth-cohort effect is 
unlikely. Why some individuals remain uninfected to the virus in old age despite a lifetime 
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possibility of exposure remains unknown. One possibility is that these individuals display a 
unique biological resilience to infection with the virus, and that this resilience is likewise 
protective against other health conditions and associated mortality. Although there may be 
intrinsic variation in biological susceptibility to infection in the population due to genetic 
factors (Sansoni et al., 2014), our age-stratified analyses showed that a strong association 
between low SES and increased prevalence of CMV remained even in old age, suggesting 
that there are indeed extrinsic factors shaping risk for infection even in old age.
Along these lines, there may likewise be extrinsic factors related to SES that modulate the 
aging immune system’s ability to keep CMV in a quiescent state. For example, low SES 
may be associated with reduced intake of micronutrients such as zinc and selenium that are 
thought to be critical to maintaining immune cells (Mocchegiani et al., 2014), and 
particularly natural killer and natural killer T cells (Mocchegiani et al., 2009),and that likely 
affect how well the body is able to control the pathogen (Tyznik et al., 2014). Furthermore, 
given strong evidence suggesting that CMV reactivation is triggered by psychosocial stress 
(Caserta et al., 2008; Rector et al., 2014; Sarid et al., 2002) and persons of low SES are more 
likely to be exposed to stressors compared to higher SES individuals (Kristenson et al., 
2004), it is likely that the mechanisms by which CMV impacts socioeconomic disparities in 
mortality also include pathways related to increased subclinical reactivation of the virus over 
the life course. Indeed, several studies have shown that low SES is associated with increased 
levels of CMV-specific IgG antibodies, a marker of viral reactivation (Dowd et al., 2008; 
Dowd and Aiello, 2009; Dowd et al., 2012). Unfortunately, CMV IgG antibody levels were 
only available for females <50 years of age and no other biomarkers of reactivation were 
available in NHANES III, and thus the CMV mediating pathway assessed in the present 
study incorporates the mechanisms related to both CMV seropositivity and reactivation. To 
further inform intervention efforts aimed at reducing SES disparities in mortality related to 
CMV infection, future studies should attempt to tease out which portion of the mediating 
effect is due to seropositivity compared to the portion that is attributable to reactivation.
We also observed that age modified the overall associations between SES and all-cause 
mortality, with the nature of the modification depending on the SES metric assessed. While 
low income was more strongly associated with increased mortality in the oldest age groups, 
educational attainment was more strongly associated with mortality in the youngest age 
group. Thus, income may be a better metric for capturing socioeconomic disparities in 
mortality among older individuals, while education may be a more sensitive metric in 
younger populations. These differences may also be attributable to temporal changes in the 
relative meaning of education in relation to socioeconomic trajectories (National Research 
Counscil Panel on Race, 2004) or to a birth-cohort effect related to widening educational 
disparities in mortality over time (Hummer and Hernandez, 2013).
An important strength of our study is that we employed the new IORW technique to assess 
mediation (Nguyen et al., 2015), which overcomes many of the limitations of traditional 
approaches that assess mediation through standard adjustment methods (i.e., comparison of 
estimates from models with and without adjustment for the mediator). However 
(Schisterman et al., 2009; Lange and Hansen, 2011), like all mediation analyses, the validity 
of our results also hinge on the assumption of no confounding after adjusting for measured 
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covariates with respect to the effects of (1) the exposure on the mediator, (2) the exposure on 
the outcome, and (3) the mediator on the outcome, and that (4) none of the confounders of 
the effect of the mediator on the outcome are affected by the exposure (Nguyen et al., 2015).
Trajectories of socioeconomic status, and particularly educational attainment, are frequently 
set relatively early in the life course. Another simplifying assumption we make in the 
interpretation of our results is that CMV infection, which is generally acquired in childhood 
or adolescence (Harrison, 2014), does not itself cause lower educational attainment and 
income. Indeed, there is some evidence that CMV infection and reactivation may play a role 
in cognitive decline in the elderly (Aiello et al., 2006; Barnes et al., 2015), pointing to a 
potential mechanism by which CMV could impact SES. A prior cross-sectional study based 
on the NHANES III study population did not, however, support an association between 
CMV seropositivity and cognitive function in children (Tarter et al., 2014). Future 
longitudinal studies may, however, be warranted to further elucidate the potential bi-
directional relationship between SES and CMV infection across the life course in relation to 
mortality.
The focus of the present analysis was to examine the extent to which CMV mediates the 
association between SES and all-cause mortality. However, future studies disentangled by 
cause of death may provide additional information about how CMV contributes to 
socioeconomic disparities in mortality. Indeed, prior studies have implicated CMV 
specifically in CVD-related mortality (Simanek et al., 2011; Savva et al., 2013) and some 
evidence suggests that the virus may contribute to cancer-related deaths as well (Barami, 
2010; Herbein and Kumar, 2014; Michaelis et al., 2009; Soderberg-Naucler, 2006). Among 
the elderly, it may also be informative to examine the association between CMV and deaths 
due to accidents, as prior evidence suggests that CMV may play an important role in frailty 
(Wang et al., 2010). Furthermore, to our knowledge, no studies have specifically examined 
the role of other prevalent latent infections, such as herpes simplex virus (HSV)-1 and 
Helicobacter pylori, in mediating the SES-mortality association in the general US 
population. Although some evidence suggests that infection with CMV, but not other 
persistent herpesviruses, influences immune aging36 and prior studies have not found an 
association between HSV-1 or H. pylori seropositivity with mortality (Chen et al., 2013; 
Simanek et al., 2015), the extent to which other persistent pathogens contribute to SES 
disparities in mortality may warrant further investigation.
Overall, our findings suggest that CMV may partially contribute to socioeconomic 
disparities in all-cause mortality among adults in the United States. We observed modest, but 
statistically significant indirect effects of SES on all-cause mortality mediated through CMV. 
Two components affect the magnitude of the indirect effect estimates, including (1) the 
association between SES and CMV and (2) the association between CMV and mortality. 
Our results suggested that the SES-CMV association was a much stronger contributor to the 
indirect effects than the CMV-mortality association, and thus interventions that target the 
former pathway may have a greater impact on reducing socioeconomic disparities in 
mortality mediated through CMV. However, as CMV is a highly prevalent virus (Staras et 
al., 2006), neither pathway is negligible with regard to its potential contribution to 
socioeconomic disparities in mortality. As CMV is generally acquired in the early life course 
Feinstein et al. Page 11
Mech Ageing Dev. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(Harrison, 2014), it may also be more feasible to target the CMV-mortality pathway, for 
example by addressing psychosocial stressors that may contribute to CMV reactivation over 
the life course. Prophylactic vaccination could also be considered, although thus far there are 
few candidate vaccines (Pass et al., 2009). Moreover, although the indirect effects of SES on 
mortality mediated through CMV did not vary substantially with age, the individual 
components comprising the indirect effects (i.e., the SES-CMV and the CMV-mortality 
associations) were modified by age, with CMV more strongly associated with mortality in 
older individuals. Thus, the mechanisms by which CMV contributes to socioeconomic 
disparities in all-cause mortality are likely intertwined with the mechanism underlying 
human aging and future interventions for reducing socioeconomic disparities related to 
CMV should be designed to address specific risk factors that may change over the life 
course.
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Fig. 1. 
Study Flow.
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Fig. 2. 
a–c. Covariate-adjusted Kaplan-Meier Failure Curves for All-cause Mortality Plotted by 
Household Income, Educational Attainment, and Cytomegalovirus (CMV) Seropositivity, 
National Health and Nutrition Examination Survey III, 1988–1994.
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Fig. 3. 
a–b. Associations Between Socioeconomic Status (Household Income Level and 
Educational Attainment), CMV Seropositivity, and All-cause Mortality Among US Adults 
≥25 Years of Age, National Health and Nutrition Examination Survey III, 1988–1994.
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Fig. 4. 
a–b. Associations Between Socioeconomic Status (Household Income Level and 
Educational Attainment), CMV Seropositivity, and All-cause Mortality Among US Adults 
≥60 Years of Age, National Health and Nutrition Examination Survey III, 1988–1994.
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